AstraZeneca’s genomic research requires extensive computational resources to analyze DNA sequences for developing life-saving therapies. As cloud infrastructure evolves with more powerful capabilities, customers can adopt them to see …
Read More
Proteros is a leader in structure-based drug discovery solutions, and supports pharmaceutical, biotechnological, and academic clients with advanced technologies like Cryogenic Electron Microscopy (Cryo-EM) and Protein Crystallography (PX). …
Read More
AWS re:Invent 2025 returns to Las Vegas, Nevada on December 1, uniting AWS builders, customers, partners, and IT professionals from across the globe. This year’s event offers you exclusive access to compelling customer stories and insights …
Read More
This post was contributed by U. Deva Priyakumar, Rakesh Srivatsava, Prathit Chatterjee, Vladimir Aladinskiy, Ramanathan Sethuraman, Yusong Wang, Alex Iankoulski, and Beryl Rabindran Today, we’re excited to announce the release of a …
Read More
Given a three-dimensional model of a drug’s potential target (the binding site), what is the orientation of the drug candidate molecule that best “fits” (docks onto) this binding site? Structure-based drug design involves the use of …
Read More
Streamline your genomic and multiomic data analysis with DRAGEN on Amazon EC2 F2 instances. Our latest blog post explores the performance benefits of this hardware-accelerated solution, helping you unlock insights faster.
Read More
In this blog post, we’re excited to share how Novo Nordisk, Columbia University and AWS collaborated to create OpenFold3, a state-of-the-art protein structure prediction model, using cost-effective and scalable bioinformatics solutions on …
Read More
In this blog post, we’re excited to share how Novo Nordisk, Columbia University and AWS collaborated to create OpenFold3, a state-of-the-art protein structure prediction model, using cost-effective and scalable bioinformatics solutions on …
Read More